CynergisTek Reports Healthcare Data Security Is a Patient Safety Issue
30 Septembre 2021 - 7:54PM
Business Wire
Multiple clients rely on CynergisTek for cyber
resilience strategic services to continue the momentum of security
programs to meet rising patient safety concerns
CynergisTek (NYSE American: CTEK), a leading cybersecurity,
privacy, compliance, and IT audit firm helping organizations in
highly regulated industries navigate emerging security and privacy
issues, announces an increase in both new multiple client deals and
renewals with nationally recognized health systems for cyber
resilience strategic services including an expanded multi-year
Resilience Partner Program and Virtual CISO services.
During the COVID-19 pandemic, healthcare IT security responded
to standing up remote work, telehealth, and outfitting hospitals to
handle the influx of patients with COVID-19 by instituting measures
to maintain business continuity and protecting against new cyber
threats due to the increased threat landscape. This resulted in
many existing cybersecurity projects, including consulting placed
on hold, canceled, or diminished in nature. As the healthcare
industry returns to a new normal, IT security investment and demand
for services to shore up their defensive and offensive strategy to
address the increase in cyberattacks is starting to resurface.
Ponemon Institute’s recent survey of hundreds of healthcare
organizations acknowledges that more than 20% of those who
responded said that mortality rates have risen as a result of
ransomware attacks, reinforcing that cybersecurity is a patient
safety concern.
“A paradigm shift is happening in the industry, organizations
recognize the need to move to become more resilient – the ability
to avoid and withstand attacks which have become a regular
occurrence and are now impacting patient care. CynergisTek is
primed to help organizations prepare, rehearse, and validate
security through its Resilience Partner Program and Virtual CISO
services,” said Mac McMillan, CEO and President at CynergisTek. The
company’s Resilience Partner Program is a multi-year partnership
focusing on helping clients meet goals aimed to improve and
maintain their security posture. Virtual CISO services provide
clients with an experienced and seasoned security resource to work
with the existing IT security team on special projects, filling in
for a vacant CISO, remediation, project management, and board-level
involvement. “Both of these services assist our clients in
responding to this critical challenge and these recent renewals and
expansions confirm our clients are focusing on security and
appreciate the value we deliver year in and year out.”
About CynergisTek, Inc.
CynergisTek (www.cynergistek.com), is a top-ranked cybersecurity
consulting firm helping organizations in highly-regulated
industries, including those in healthcare, government, and finance
navigate emerging security and privacy issues. CynergisTek combines
intelligence, expertise, and a distinct methodology to validate a
company's security posture and ensure the team is rehearsed,
prepared, and resilient against threats. Since 2004, CynergisTek
has been dedicated to hiring and retaining experts who bring
real-life experience and hold advanced certifications to support
and educate the industry by contributing to relevant industry
associations. For more information, visit www.cynergistek.com or
follow us on Twitter or Linkedin.
Cautionary Note Regarding Forward Looking Statements
This release contains certain forward-looking statements
relating to the business of CynergisTek, Inc.. These
forward-looking statements are within the meaning of Section 27A of
the Securities Act of 1933, as amended (the “Securities Act”) and
Section 21E of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”) and can be identified by the use of forward-looking
terminology such as “believes,” “expects,” “anticipates,” “would,”
“could,” “intends,” “may,” “will,” or similar expressions. Such
forward-looking statements involve known and unknown risks and
uncertainties, including but not limited to uncertainties relating
to product/services development; long and uncertain sales cycles;
the ability to obtain or maintain proprietary intellectual property
protection; future capital requirements; competition from other
providers; the ability of the Company’s vendors to continue
supplying the Company with supplies and services at comparable
terms and prices; the Company’s ability to successfully compete and
introduce enhancements and new features that achieve market
acceptance and that keep pace with technological developments; the
Company’s ability to maintain its brand and reputation and retain
or replace its significant customers; cybersecurity risks and risks
of damage and interruptions of information technology systems; the
Company’s ability to retain key members of management and
successfully integrate new executives; the Company’s ability to
complete acquisitions, strategic investments, entry into new lines
of business, divestitures, mergers or other transactions on
acceptable terms, or at all; potential risks and uncertainties
relating to the existing and ultimate impact of COVID-19, including
the geographic spread, the severity of the virus, the duration of
the COVID-19 outbreak, actions that may be taken by governmental
authorities to contain the COVID-19 outbreak or to treat its
impact, and the potential negative impacts of COVID-19 on the
global economy and financial markets, and other factors that may
cause actual results to be materially different from those
described herein as anticipated, believed, estimated or expected.
Certain of these risks and uncertainties are or will be described
in greater detail in the Company’s Form 10-K and Form 10-Q filings
with the Securities and Exchange Commission, which are available at
http://www.sec.gov. Given the risks and uncertainties, readers
should not place undue reliance on any forward-looking statement
and should recognize that the statements are predictions of future
results which may not occur as anticipated. Many of the risks
listed above have been, and may further be, exacerbated by the
COVID-19 pandemic, including its impact on the healthcare industry.
Actual results could differ materially from those anticipated in
the forward-looking statements and from historical results, due to
the risks and uncertainties described herein, as well as others not
now anticipated. CynergisTek is under no obligation (and expressly
disclaims any such obligation) to update or alter its
forward-looking statements whether as a result of new information,
future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210930005887/en/
Investor Relations Contact:
CynergisTek, Inc. Paul Anthony
InvestorRelations@cynergistek.com
Media Contact:
Allison + Partners Jaime Tero 415-755-8639
jaime.tero@allisonpr.com
CynergisTek (AMEX:CTEK)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
CynergisTek (AMEX:CTEK)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024